Study Details
A Study to Test Nasal Swab to Predict If a Lung Nodule is Cancerous
(IRB#: IRB_00168224)
Percepta Nasal Swab Classifier is a genetic tool used to see if the risk of lung cancer is related to finding a lung nodule (unneeded tissue found in the lungs). The tool may be applied at a clinic visit when a person is tested for lung cancer or other medical reasons. The test is done by swabbing inside the nose with a small brush. The study wants to see if the Percepta Nasal Swab Classifier will help doctors and patients know if they are at risk for lung cancer. People in this study will be randomly treated with the Percepta Nasal Swab Classifier. If a person is in the test group, the doctor will receive and share results that may be used in addition to the medical care of a person. If a person is not in the test group, the doctor will not receive results and still provide medical care to assess the risk of lung cancer. Participation in the study is about 2.5 years. Participants will be paid $50 for completing the study visit. The test will be done at an in-person clinic visit.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 29 to 85 years old
- A new nodule first seen in imaging (a picture taken using a machine to scan parts of the body such as a CT scan) within the past 90 days of participation
- Current or former smoker
- Attend in person at a University of Utah clinic
Exclusion Criteria
- Active cancer
- Prior primary lung cancer
- Current active treatment of another study device or drug
Will I be paid for my time?
Yes
IRB#: IRB_00168224
PI: Chakravarthy Reddy
Department: PULMONARY
Approval Date: 2023-09-06 06:00:00
Specialties: Pulmonary